benzimidazole has been researched along with bms 536924 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carboni, JM; Clarke, W; Frennesson, DB; Gottardis, M; Greer, A; Lee, FY; Li, A; Liu, P; Menard, K; Saulnier, MG; Trainor, G; Velaparthi, U; Vyas, D; Wittman, MD; Yang, Z; Zimmermann, K | 1 |
1 other study(ies) available for benzimidazole and bms 536924
Article | Year |
---|---|
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one.
Topics: Administration, Oral; Animals; Benzimidazoles; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Mice; Mice, Nude; Piperazines; Protein Kinase Inhibitors; Pyridones; Rats; Receptor, IGF Type 1; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2010 |